Grace Liang

机构：Neurocrine Biosciences (United States) · ORCID：0009-0008-2581-4891

发表论文 88 篇 · 总被引 2192 次 · h-index 22

代表论文

Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients (2022 · JAMA Cardiology · 被引 191)
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial (2023 · The Lancet Neurology · 被引 66)
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder (2025 · Psychopharmacology Bulletin · 被引 23)
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder (2025 · Psychopharmacology Bulletin · 被引 23)
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder (2025 · Psychopharmacology Bulletin · 被引 13)
Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study (2022 · Parkinsonism & Related Disorders · 被引 11)